By Jacob Ufberg, MD Assistant Professor of Emergency Medicine, Residency Program Director, Department of Emergency Medicine, Temple University School of Medicine, Philadelphia, PA Dr. Ufberg discloses that he is a researcher for Pfizer Pharmaceuticals. Source: Mills GD, et al. Effectiveness of beta-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330:456-460.
By Jacob Ufberg, MD Assistant Professor of Emergency Medicine, Residency Program Director, Department of Emergency Medicine, Temple University School of Medicine, Philadelphia, PA Dr. Ufberg discloses that he is a researcher for Pfizer Pharmaceuticals. Source: Mills GD, et al. Effectiveness of beta-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330:456-460.
Rethinking Antibiotic Therapy for Mild-to-Moderate CAP
August 1, 2005